// Boots and Superdrug warn on hay fever pill shortages
// Piriton and Piriteze tablets, made by GSK, are currently out of stock
Boots and Superdrug have reported shortages for some of their hay fever medicines, blaming supply chain issues.
Piriton and Piriteze tablets, made by GSK, are currently out of stock at Boots and other chains due to an industry-wide shortage of the active ingredient, chlorphenamine maleate.
The products are expected to be back on shelves within the next few weeks.
READ MORE: Boots unveils its first ever TV advert for Advantage Card
GSK said its Piriteze allergy syrup, which is given to children, was not affected by the problems.
Boots said only four of its 90 hay fever relief products were affected by the shortages – Piriton tablets and its own-brand version, both sold in different pack sizes.
“At Boots we have a large range of hay fever relief medicines, with good availability of stock overall in our stores and online,” Boots said.
“There are a very small number of lines that are currently out of stock due to a current, industry-wide shortage of the active ingredient.
“However, we are expecting this to be resolved soon and new deliveries are expected in the coming weeks.”
Superdrug said it was experiencing shortages of two products, Piriton 30s and 60s tablets packs, but it had many alternatives such as its own-brand allergy ranges with the active ingredients loratadine or cetirizine, and another medicine, Allevia.
Click here to sign up to Retail Gazette‘s free daily email newsletter
